ShedRx vs Gala Health
Two GLP-1 providers, one scoreboard. We put ShedRx and Gala Health head-to-head on the published Brief Score — the same six factors, scored the same way.
ShedRx
The verdict
ShedRx takes this head-to-head.
ShedRx scores 87 to 82 on our six-factor Brief Score — A weight-focused program with a low tracked tirzepatide rate and an oral/sublingual route for the needle-averse.
That doesn't make Gala Health a bad call — it's best for readers ready to commit to a year of compounded tirzepatide up front, who want it available in all 50 states and like knowing a brand-name ozempic route exists if they ever switch — and who value a menopause/hrt program alongside the glp-1. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| ShedRx | Gala Health | |
|---|---|---|
| Brief Score | 87/100 (B+) | 82/100 (B−) |
| Semaglutide | $199/mo on the 1-month plan · $179/mo on 6 months · $159/mo only on a 12-month commitment (all plans carry a 2-month minimum) | Compounded semaglutide is included in the same From $179/mo yearly-subscription plan; brand-name Ozempic from $1,299/mo cash |
| Tirzepatide | $299/mo on the 1-month plan · $269/mo on 6 months · $239/mo only on a 12-month commitment (all plans carry a 2-month minimum) | From $179/mo only on the yearly subscription; $199/mo on the 3-month plan (all doses included) |
| Coverage | Not disclosed | All 50 states |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Yes | Injection only |
| On the tracker | Fallingprice falling | Stableprice stable |
ShedRx: Its lowest tirzepatide rate is $239, and that needs the 12-month commitment; the one-month rung is $299.
Gala Health: Headline compounded-tirz rate unchanged this cycle, but it is a yearly-subscription price — the shortest published plan is three months at $199/mo, and no month-to-month rate exists.
● Not sold on either?
CoreAge Rx tops the whole ranking at 94/100.
One price on both molecules that does not climb as you titrate — but the headline $99 and $149 are annual-plan rates, paid in full up front.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.